Current Consensus on I-131 MIBG Therapy
Sign Up to like & getrecommendations! Published in 2018 at "Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s13139-018-0523-z
Abstract: Metaiodobenzylguanidine (MIBG) is structurally similar to the neurotransmitter norepinephrine and specifically targets neuroendocrine cells including some neuroendocrine tumors. Iodine-131 (I-131)-labeled MIBG (I-131 MIBG) therapy for neuroendocrine tumors has been performed for more than a quarter-century.… read more here.
Keywords: unresectable metastatic; 131 mibg; mibg therapy; mibg ... See more keywords
131I-MIBG Therapy in a Metastatic Small Bowel Neuroendocrine Tumor Patient Undergoing Hemodialysis.
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000001601
Abstract: Systemic radioisotope therapy with I-metaiodobenzylguanidine (I-MIBG) is an effective form of targeted therapy for neuroendocrine tumors. One of the absolute contraindications to administering I-MIBG therapy listed in the 2008 European Association of Nuclear Medicine guidelines… read more here.
Keywords: metastatic small; medicine; small bowel; mibg therapy ... See more keywords
Low-Dose, Low-Specific Activity 131I-metaiodobenzyl Guanidine Therapy in Metastatic Pheochromocytoma/Sympathetic Paraganglioma: Single-Center Experience from Western India
Sign Up to like & getrecommendations! Published in 2021 at "Indian Journal of Endocrinology and Metabolism"
DOI: 10.4103/ijem.ijem_52_21
Abstract: Introduction: Radionuclide therapy is a promising treatment modality in metastatic pheochromocytoma/paraganglioma (PPGL). There is scarce data on 131I-metaiodobenzyl guanidine (131I-MIBG) therapy from the Indian subcontinent. Hence, we aim to study the safety and effectiveness of… read more here.
Keywords: therapy; 131i mibg; response; mibg therapy ... See more keywords
131-I MIBG therapy of malignant pheochromocytoma and paraganglioma tumours - a single-centre study.
Sign Up to like & getrecommendations! Published in 2018 at "Endokrynologia Polska"
DOI: 10.5603/ep.a2018.0024
Abstract: INTRODUCTION Pheochromocytomas and paragangliomas are rare tumors deriving from chromaffin cells of adrenal medulla or paraganglia. They are usually benign but 10-35% of them present malignant behavior. The aim of the study was to evaluate… read more here.
Keywords: 131 mibg; mibg therapy; treatment; study ... See more keywords